Bulgarelli, Adriana; Leite Junior, Antonio Carlos de Arruda; Dias, Adriana Abalen Martins; Maranhão, Raul Cavalcante 
Fonte: Cardiovascular Drugs and Therapy. Unidade: FCF
Assuntos: LIPOPROTEÍNAS LDL, ARTRITE REUMATOIDE, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BULGARELLI, Adriana et al. Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits. Cardiovascular Drugs and Therapy, v. 27, n. 6, p. 531-539, 2013Tradução . . Disponível em: https://doi.org/10.1007/s10557-013-6488-3. Acesso em: 18 maio 2024.APA
Bulgarelli, A., Leite Junior, A. C. de A., Dias, A. A. M., & Maranhão, R. C. (2013). Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits. Cardiovascular Drugs and Therapy, 27( 6), 531-539. doi:10.1007/s10557-013-6488-3NLM
Bulgarelli A, Leite Junior AC de A, Dias AAM, Maranhão RC. Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits [Internet]. Cardiovascular Drugs and Therapy. 2013 ; 27( 6): 531-539.[citado 2024 maio 18 ] Available from: https://doi.org/10.1007/s10557-013-6488-3Vancouver
Bulgarelli A, Leite Junior AC de A, Dias AAM, Maranhão RC. Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits [Internet]. Cardiovascular Drugs and Therapy. 2013 ; 27( 6): 531-539.[citado 2024 maio 18 ] Available from: https://doi.org/10.1007/s10557-013-6488-3
